BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Horton DB, Gerhard T, Davidow A, Strom BL. Impact of the black triangle label on prescribing of new drugs in the United Kingdom: lessons for the United States at a time of deregulation. Pharmacoepidemiol Drug Saf 2017;26:1307-13. [PMID: 28857309 DOI: 10.1002/pds.4304] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Januskiene J, Segec A, Slattery J, Genov G, Plueschke K, Kurz X, Arlett P. What are the patients' and health care professionals' understanding and behaviors towards adverse drug reaction reporting and additional monitoring? Pharmacoepidemiol Drug Saf 2021;30:334-41. [PMID: 33099846 DOI: 10.1002/pds.5162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Selke Krulichová I, Selke GW, Eichler U, Lappe V, Godman B, Schubert I. Impact of EU risk assessment process and administrative regulations for manufacturers of combined hormonal contraceptive prescribing. An analysis of developments in Germany and the implications. Current Medical Research and Opinion 2019;35:697-704. [DOI: 10.1080/03007995.2018.1541317] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
3 Said A, Freudewald L, Parrau N, Ganso M, Schulz M. Pharmacists' perception of educational material to improve patient safety: A cross-sectional study on practices and awareness in Germany. Medicine (Baltimore) 2021;100:e25144. [PMID: 33725997 DOI: 10.1097/MD.0000000000025144] [Reference Citation Analysis]